HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

C 205

RN given refers to parent cpd

Also Known As:

C 205, dihydrochloride; C-205

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Acridines: 325
      - C 205: 3

Experts

1.	Battelino, Tadej: 1 article (02/2018)
2.	Bertok, Sara: 1 article (02/2018)
3.	Groselj, Urh: 1 article (02/2018)
4.	Kovac, Jernej: 1 article (02/2018)
5.	Perko, Dasa: 1 article (02/2018)
6.	Repic Lampret, Barbka: 1 article (02/2018)
7.	Smon, Andraz: 1 article (02/2018)
8.	Trebusak Podkrajsek, Katarina: 1 article (02/2018)
9.	Zerjav Tansek, Mojca: 1 article (02/2018)
10.	Inano, Shojiro: 1 article (08/2017)

Related Diseases

1.	Chromosome Breakage 08/01/2017 - "Cells from the patient carrying the compound heterozygous mutations c.205_206dupCC and c.1916T>A in RFWD3 showed increased sensitivity to DNA interstrand cross-linking agents in terms of increased chromosomal breakage, reduced survival, and cell cycle arrest in G2 phase. "
2.	Carcinoma (Carcinomatosis) 07/01/1986 - "Hemin failed to protect four of the five nonhemopoietic cell lines tested, including MCF-, breast adenocarcinoma cells, C-205 colon carcinoma cells, mouse 3T3 fibroblasts, and mouse kidney VERO cells. "
3.	Adenocarcinoma 07/01/1986 - "Hemin failed to protect four of the five nonhemopoietic cell lines tested, including MCF-, breast adenocarcinoma cells, C-205 colon carcinoma cells, mouse 3T3 fibroblasts, and mouse kidney VERO cells. "
4.	VLCAD deficiency 02/01/2018 - "A patient with suspected very long-chain acyl-CoA dehydrogenase deficiency had negative metabolic follow-up tests, but had two heterozygous ACADVL variants; one known disease-causing variant and one indel, namely c.205-8_205-7delinsGC, that is predicted to be causative. "

Related Drugs and Biologics

1.	Hemin (Panhematin)
2.	DNA (Deoxyribonucleic Acid)